Bronchiolitis is another childhood's disease, which is caused by a virus. Dr. Hand talks about the symptoms of bronchiolitis and how to treat it.
Read the full transcript »
Treating Bronchiolitis Bronchiolitis is another childhood disease that is very prevalent. It’s prevalent especially during the peak months of October and April because that’s when the respiratory syncytial virus otherwise known as the RSV virus. R is most prevalent. This is a self limited disease lasting about a week which hits at its peak at around the fourth day, and it tends to disappear at the seventh or eighth day. It presents with runny nose, cough and an expiratory wheeze. It basically is an asthma imitator. The fever tends to be little grayed. The physical findings are those of wheezing, prolonged expiratory phase that is prolonged breathing out in the lungs is heard. With a wheeze, it’s created by the narrowing of the airway. This disease is caused by other viruses set within the RSV virus. You can see it with influenza, influenza virus, rhinoviruses, adenoviruses, microplasma, but basically it’s become synonymous with the RSV virus. It is a basically an inflammation with associated obstruction of the peripheral airways. It’s below the larynx and therefore, it differs from croup which we’ve talked about because it’s a lower respiratory tract disease as opposed to upper respiratory tract disease. It’s also most prevalent under two years of age. It’s a big problem clinically is that it imitates asthma, and therefore the treatment often instituted first is the anti-asthma therapy because of its symptoms being identical to asthma. It also is very controversial whether the asthma therapy had any role in the treatment of bronchiolitis since asthma, which has the inflammation but is broncho’s fast rate where a bronchiolitis is inflammation of the airway and now here the airway, technically, the treatments for asthma do not exactly fit what you’d expect for bronchiolitis. Nevertheless, management usually does include fluids, some oxygen if the child has any oxygenation defect, bronchodilators such as buterol or it’s light drugs often tried with little success with this disease -- steroids are extremely controversial in this disease and have long been the source of investigation for the effectiveness. Antibiotics have no roles since this is a viral disease but there is anti viral therapy for the very severe bronchiolitis, and there are guidelines set apart or set aside by the Academy of Pediatrics published in their Red Book that are used for the Rivoviron therapy which is given in the hospitals for the severe bronchiolitic in respiratory failure. Right now, its main focus has been the recognition first of the RSV immune globula and it was given, and now, the monoclonal antibody profile access is given to sets of kids who have either respiratory or cardiovascular -- chronic respiratory cardiovascular disease or have certain criteria of prematurity and of therapy in a Neoneedle setting, which makes them especially predisposed to severity with this disease. There is their question that we may have at sometimes that RSV viral vaccine that will be given -- that will be making major difference in prevention of this disease.